Anatomical and Functional Imaging Correlates of Chronic Pain in Cerebral Palsy
Launched by HUGO W. MOSER RESEARCH INSTITUTE AT KENNEDY KRIEGER, INC. · Jan 14, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how chronic pain and sensory issues in individuals with cerebral palsy (CP) are connected to changes in the brain. Researchers will use MRI scans, which are special pictures of the brain, to look for patterns that show how the brain is affected in people with CP who experience pain. The goal is to better understand the relationship between brain changes and chronic pain, which can help improve treatment options for those affected.
To participate, individuals must be at least 8 years old and have a diagnosis of cerebral palsy. There are two groups in the study: one group will only answer surveys, while the other group will also undergo MRI scans. Participants will need to lie still in the MRI machine for about 1.5 hours. There are no specific health conditions that would exclude participants, but they should be able to understand the study and provide consent. This trial is currently recruiting and is open to people of all genders.
Gender
ALL
Eligibility criteria
- Participants with CP (Survey-only):
- Inclusion Criteria:
- • Individual 8+ years of age
- • Diagnosis of cerebral palsy
- Exclusion Criteria:
- • -None
- Neurotypical participants: (Survey-only):
- Inclusion Criteria:
- • Individual 8+ years of age
- • Adult subject able to indicate understanding and affirmative consent OR Adult/child subject unable to indicate understanding and affirmative consent AND subject assents AND LAR consents
- Exclusion Criteria:
- • -Clinically-significant neurologic or developmental diagnosis
- Participants with CP (Survey and MRI):
- Inclusion Criteria:
- • Individual 8+ years of age
- • Adult subject able to indicate understanding and affirmative consent OR Adult subject unable to indicate understanding and affirmative consent AND subject assents AND LAR consents
- • Diagnosis of cerebral palsy
- • Clinical imaging demonstrating isolated periventricular white matter injury
- • Clinical judgment that all neurologic symptoms are attributable to non-progressive periventricular white matter injury
- • Able to lie still in scanner for 1.5 hours in at most 2 sessions and be able to have MRI
- Exclusion Criteria:
- • -None
- Neurotypical participants (Survey and MRI):
- Inclusion Criteria:
- • Individual 8+ years of age
- • Adult subject able to indicate understanding and affirmative consent
- • Able to lie still in scanner for 1.5 hours and be able to have MRI
- Exclusion Criteria:
- • -Clinically-significant neurologic or developmental diagnosis
About Hugo W. Moser Research Institute At Kennedy Krieger, Inc.
The Hugo W. Moser Research Institute at Kennedy Krieger, Inc. is a leading research institution dedicated to advancing the understanding and treatment of neurodevelopmental disorders. With a strong focus on innovative scientific research, the Institute fosters collaboration among experts in various fields, including neuroscience, genetics, and rehabilitation. By conducting rigorous clinical trials and studies, the Institute aims to translate findings into effective interventions that improve the quality of life for individuals with disabilities. Its commitment to excellence in research and patient care positions it as a pivotal player in the advancement of pediatric healthcare and therapeutic solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Baltimore, Maryland, United States
Baltimore, Maryland, United States
Baltimore, Maryland, United States
Baltimore, Maryland, United States
Patients applied
Trial Officials
Eric Chin, MD
Principal Investigator
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials